Trial Profile

Tissue Selective Estrogen Complex to Prevent Metabolic Dysfunction in Women (TSEC)

Status: Completed

Phase of Trial: Phase 0

Latest Information Update: 06 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Conjugated estrogens/bazedoxifene (Primary)
Indications Postmenopausal osteoporosis
Focus Therapeutic Use
Acronyms RISE
Sponsors Pennington Biomedical Research Center

Most Recent Events

13 Dec 2017 Status changed from recruiting to completed.
13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
26 Sep 2016 Planned End Date changed from 1 Jan 2017 to 1 Jun 2017.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com